Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinogenesis × Poly I-C × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Neoplasms 1 Melanoma 1 Glioma 1 Glioblastoma 1 Carcinogenesis 1

Interventions

Blood Specimen Collection 2 poly ICLC 1 Vinorelbine 1 Tissue Banks 1 Therapeutics 1 Reverse Transcriptase Polymerase Chain Reaction 1 Probiotics 1 Poly I-C 1 Pemetrexed 1 Paclitaxel 1 Monatide (IMS 3015) 1 Immunohistochemistry 1 Docetaxel 1 Cosmetics 1 Cisplatin 1 Carboplatin 1 Bronchoalveolar Lavage 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01079741 2018-02-13

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed

34 enrolled 10 charts

Melanoma, Neoplasms, Skin Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡